Search results for "CELLULAR"

showing 10 items of 6449 documents

Epigenetic modifications precede molecular alterations and drive human hepatocarcinogenesis

2021

Development of primary liver cancer is a multistage process. Detailed understanding of sequential epigenetic alterations is largely missing. Here, we performed Infinium Human Methylation 450k BeadChips and RNA-Seq analyses for genome-wide methylome and transcriptome profiling of cirrhotic liver (n = 7), low- (n = 4) and high-grade (n = 9) dysplastic lesions, and early (n = 5) and progressed (n = 3) hepatocellular carcinomas (HCC) synchronously detected in 8 patients with HCC with chronic hepatitis B infection. Integrative analyses of epigenetically driven molecular changes were identified and validated in 2 independent cohorts comprising 887 HCCs. Mitochondrial DNA sequencing was further em…

AdultMaleMitochondrial DNACarcinoma HepatocellularCirrhosisMolecular biologyCarcinogenesisBiologyEpigenesis GeneticHepatitis B ChronicmedicineHumansEpigeneticsAgedHepatologyGene Expression ProfilingLiver NeoplasmsDNA NeoplasmGeneral MedicineMethylationDNA MethylationMiddle AgedHCCSmedicine.diseaseGene Expression Regulation NeoplasticOncologyApoptosisDNA methylationCancer researchEpigeneticsCalmodulin-Binding ProteinsFemaleLiver cancerLiver cancerResearch ArticleJCI Insight
researchProduct

Conduction times of cortical projections to paravertebral muscles in controls and in patients with multiple sclerosis

1994

AdultMaleMultiple SclerosisElectrodiagnosisPhysiologymedicine.medical_treatmentNeural ConductionNerve conduction velocityCentral nervous system diseaseCellular and Molecular NeurosciencePhysiology (medical)Neural PathwaysmedicineHumansIn patientmedicine.diagnostic_testbusiness.industryMultiple sclerosisMotor CortexAnatomyMiddle Agedmedicine.diseaseSpineTranscranial magnetic stimulationmedicine.anatomical_structureParavertebral musclesFemaleNeurology (clinical)businessMotor cortexMuscle & Nerve
researchProduct

Preselection of cases through expert clinical and radiological review significantly increases mutation detection rate in multiple epiphyseal dysplasia

2006

Skeletal dysplasias are difficult to diagnose for the nonexpert. In a previous study of patients with multiple epiphyseal dysplasia (MED), we identified cartilage oligomeric matrix protein (COMP) mutations in only 36% of cases and suspected that the low-mutation detection rate was partially due to misdiagnosis. We therefore instituted a clinical–radiographic review system, whereby all cases were evaluated by a panel of skeletal dysplasia experts (European Skeletal Dysplasia Network). Only those patients in whom the diagnosis of MED was confirmed by the panel were screened for mutations. Under this regimen the mutation detection rate increased to 81%. When clinical–radiological diagnostic cr…

AdultMaleMutation ratemedicine.medical_specialtyDNA Mutational AnalysisCartilage Oligomeric Matrix ProteinOsteochondrodysplasiasArticleMultiple epiphyseal dysplasiaGeneticsmedicineHumansMatrilin ProteinsGenetic TestingGenetics (clinical)Genetic testingGlycoproteinsCartilage oligomeric matrix proteinExtracellular Matrix Proteinsmedicine.diagnostic_testbiologybusiness.industryCartilageMiddle Agedmedicine.diseaseRadiographyRegimenmedicine.anatomical_structureDysplasiaChild PreschoolMutation (genetic algorithm)Mutationbiology.proteinFemaleRadiologybusiness
researchProduct

Plasticity of brain wave network interactions and evolution across physiologic states

2015

Neural plasticity transcends a range of spatio-temporal scales and serves as the basis of various brain activities and physiologic functions. At the microscopic level, it enables the emergence of brain waves with complex temporal dynamics. At the macroscopic level, presence and dominance of specific brain waves is associated with important brain functions. The role of neural plasticity at different levels in generating distinct brain rhythms and how brain rhythms communicate with each other across brain areas to generate physiologic states and functions remains not understood. Here we perform an empirical exploration of neural plasticity at the level of brain wave network interactions repre…

AdultMaleNerve netCognitive NeuroscienceNeuroscience (miscellaneous)Sensory systemPlasticityCognitive neurosciencelcsh:RC321-571Young AdultCellular and Molecular NeuroscienceNeuroplasticitymedicineHumanslcsh:Neurosciences. Biological psychiatry. NeuropsychiatryOriginal ResearchSlow-wave sleepCerebral CortexNetwork physiologySleep StagesNeuronal PlasticityBrain WaveBrain wave interactions; Network physiology; Neural plasticity; Sleep; Time delay stability; Adult; Brain Waves; Cerebral Cortex; Female; Humans; Male; Nerve Net; Neuronal Plasticity; Sleep; Young Adult; Neuroscience (miscellaneous); Cellular and Molecular Neuroscience; Sensory Systems; Cognitive NeuroscienceNetwork dynamicsBrain WavesSettore FIS/07 - Fisica Applicata(Beni Culturali Ambientali Biol.e Medicin)Sensory Systemsbrain wave interactionsmedicine.anatomical_structureBrain wave interactionFemaletime delay stabilityNerve NetSensory SystemPsychologySleepNeuroscienceHumanNeuroscienceneural plasticityFrontiers in Neural Circuits
researchProduct

Impact of Individual Components of the Metabolic Syndrome on the Outcome of Patients with Advanced Hepatocellular Carcinoma Treated with Sorafenib

2017

<b><i>Background/Aim:</i></b> Individual components of the metabolic syndrome (MS) such as obesity or diabetes mellitus impair the prognosis of patients with hepatocellular carcinoma (HCC) following curative treatment approaches or transarterial therapies. The aim of this retrospective study was to assess the impact of these factors on the overall survival (OS) of patients with advanced HCC treated with sorafenib. <b><i>Methods:</i></b> Univariate and multivariate analyses were performed to assess the impact of individual components of the MS on the OS of 152 consecutive patients with advanced HCC treated with sorafenib. <b><i>Resu…

AdultMaleNiacinamideOncologySorafenibmedicine.medical_specialtyCarcinoma HepatocellularAntineoplastic AgentsYoung Adult03 medical and health sciences0302 clinical medicineDiabetes mellitusInternal medicinemedicineHumansSurvival analysisAgedNeoplasm StagingProportional Hazards ModelsRetrospective StudiesAged 80 and overMetabolic Syndromebusiness.industryProportional hazards modelPhenylurea CompoundsLiver NeoplasmsHazard ratioGastroenterologyGeneral MedicineMiddle AgedSorafenibPrognosismedicine.diseaseSurvival Analysisdigestive system diseasesTreatment OutcomeDiabetes Mellitus Type 2030220 oncology & carcinogenesisHepatocellular carcinomaMultivariate AnalysisFemale030211 gastroenterology & hepatologyMetabolic syndromebusinessDyslipidemiamedicine.drugDigestive Diseases
researchProduct

Association of a variant in the muscarinic acetylcholine receptor 2 gene (CHRM2 ) with nicotine addiction

2009

Genetic factors contribute to the overall risk of developing nicotine addiction, which is the major cause of preventable deaths in western countries. However, knowledge regarding specific polymorphisms influencing smoking phenotypes remains scarce. In the present study we provide evidence that a common single nucleotide polymorphism (SNP) in the 5′ untranslated region of CHRM2, the gene coding for the muscarinic acetylcholine receptor 2 is associated with nicotine addiction. CHRM2 was defined as a candidate gene for nicotine addiction based on previous evidence that linked variations in CHRM2 to alcohol and drug dependence. A total of more than 5,500 subjects representative of the German po…

AdultMaleNicotineCandidate geneAdolescentmedia_common.quotation_subjectSingle-nucleotide polymorphismBiologyBioinformaticsNicotineCellular and Molecular NeuroscienceMuscarinic acetylcholine receptormedicineHumansSNPGenetic Predisposition to DiseaseAlleleAllelesGenetics (clinical)Agedmedia_commonAged 80 and overGeneticsReceptor Muscarinic M2AddictionSmokingGenetic VariationTobacco Use DisorderOdds ratioMiddle AgedPsychiatry and Mental healthFemalemedicine.drugAmerican Journal of Medical Genetics Part B: Neuropsychiatric Genetics
researchProduct

Variants of CARD15 are associated with an aggressive clinical course of Crohn's Disease. An IG-IBD Study

2005

Three major variants of the CARD15 gene confer susceptibility to Crohn's disease (CD). Whether or not these variants correlate with specific clinical features of the disease is under evaluation.We investigated the possible association of CARD15 variants with specific clinical characteristics, including the occurrence of anti-Saccharomyces cerevisiae antibodies (ASCA) and antineutrophil cytoplasmic antibodies (ANCA), in a large cohort of inflammatory bowel disease (IBD) patients and their unaffected relatives.Three hundred and sixteen CD patients (156 with positive family history), 408 ulcerative colitis (UC) patients (206 with positive family history), 588 unaffected relatives, and 205 unre…

AdultMaleNod2 Signaling Adaptor Proteindigestive systemCrohn DiseaseGene FrequencyHumansMedicineSettore MED/12 - GastroenterologiaCrohn's diseaseHepatologybiologyCrohn diseasebusiness.industryIntracellular Signaling Peptides and ProteinsGastroenterologyClinical courseMiddle Agedmedicine.diseasedigestive system diseasesPhenotypeItalyCase-Control StudiesMutationImmunologybiology.proteinColitis UlcerativeFemaleAntibodybusinessFollow-Up Studies
researchProduct

Trends in Epidemiology, Treatment, and Survival of Hepatocellular Carcinoma Patients Between 1998 and 2009

2013

The aim of this study was to analyze clinical presentation, course of disease, and management of patients with hepatocellular carcinoma (HCC) in a German referral center between 1998 and 2009.HCC is a rare tumor in Germany, but its incidence has increased over the last 30 years. New therapies such as chemoembolization with drug-eluting beads, selective internal radiotherapy, and sorafenib were introduced recently; however, the impact on clinical management and overall survival (OS) is unclear.In this retrospective analysis, 1066 patients with HCC, separated into two 6-year periods (n=385; 1998 to 2003 and n=681; 2004 to 2009) were evaluated.The number of patients presenting each year (64 vs…

AdultMaleOncologymedicine.medical_specialtyCarcinoma HepatocellularTime FactorsAdolescentKaplan-Meier EstimateMedical OncologyRisk AssessmentArticleTertiary Care CentersGermanYoung AdultRisk FactorsGermanyInternal medicineEpidemiologymedicineCarcinomaHumansRegistriesYoung adultAgedNeoplasm StagingProportional Hazards ModelsRetrospective StudiesAged 80 and overbusiness.industryProportional hazards modelIncidence (epidemiology)Liver NeoplasmsAge FactorsGastroenterologyRetrospective cohort studyMiddle Agedmedicine.diseasedigestive system diseaseslanguage.human_languageTreatment OutcomeHepatocellular carcinomalanguageFemalebusinessJournal of Clinical Gastroenterology
researchProduct

Cellular Phones, Cordless Phones, and the Risks of Glioma and Meningioma (Interphone Study Group, Germany)

2006

The widespread use of cellular telephones has generated concern about possible adverse health effects, particularly brain tumors. In this population-based case-control study carried out in three regions of Germany, all incident cases of glioma and meningioma among patients aged 30–69 years were ascertained during 2000–2003. Controls matched on age, gender, and region were randomly drawn from population registries. In total, 366 glioma cases, 381 meningioma cases, and 1,494 controls were interviewed. Overall use of a cellular phone was not associated with brain tumor risk; the respective odds ratios were 0.98 (95% confidence interval (CI): 0.74, 1.29) for glioma and 0.84 (95% CI: 0.62, 1.13)…

AdultMaleOncologymedicine.medical_specialtyEpidemiologyPopulationBrain tumorRisk AssessmentInterviews as TopicMeningiomaElectromagnetic FieldsRisk FactorsGermanyGliomaInternal medicineCordless phonemedicineHumansRegistriesRisk factoreducationneoplasmsAgededucation.field_of_studyBrain Neoplasmsbusiness.industryIncidenceCase-control studyEnvironmental ExposureGliomaOdds ratioMiddle Agedmedicine.diseasenervous system diseasesSurgerycellular phoneCase-Control StudiestelephoneFemaleMeningiomaRisk assessmentbusinessCell PhoneAmerican Journal of Epidemiology
researchProduct

Metastatic carcinoma of the oral region: An analysis of 21 cases

2017

Background Metastatic carcinoma to the jaws and oral region are very rare, representing less than 1% of all oral tumors. Unfortunately, oral metastasis is usually manifestation of an advanced stage of primary cancer, and indicates widespread disease and poor prognosis. Material and Methods In this retrospective study, a total of 2039 patients with history of oral malignant tumor between 1980 and 2012 at Seoul National University Dental Hospital were evaluated. We analyzed the dental and medical records, and histopathological database of 2039 patients to assess the prevalence of oral metastasis of carcinoma in terms of sex and age, as well as, the most common origin of primary cancer, and pr…

AdultMaleOncologymedicine.medical_specialtyMetastatic carcinomaMetastasis03 medical and health sciences0302 clinical medicineInternal medicineBiopsymedicineCarcinomaHumansGeneral DentistryAgedRetrospective StudiesAged 80 and overmedicine.diagnostic_testbusiness.industryResearchMedical recordRetrospective cohort study030206 dentistryMiddle Aged:CIENCIAS MÉDICAS [UNESCO]medicine.diseasestomatognathic diseasesOtorhinolaryngology030220 oncology & carcinogenesisHepatocellular carcinomaUNESCO::CIENCIAS MÉDICASAdenocarcinomaFemaleMouth NeoplasmsSurgeryRadiologyOral SurgerybusinessMedicina Oral Patología Oral y Cirugia Bucal
researchProduct